assessing < assessment < assessments

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 56.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000083 (2012)	Yasuhiko Hirabayashi [Japon] ; Tomonori Ishii [Japon]	The DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab
000160 (2011)	Susumu Nishiyama [Japon] ; Tetsushi Aita [Japon] ; Yasuhiko Yoshinaga [Japon] ; Hiroki Kishimoto [Japon] ; Michio Toda [Japon] ; Yoshiki Yoshihara [Japon] ; Shinya Miyoshi [Japon] ; Akira Manki [Japon] ; Shoji Miyawaki [Japon]	Proposing a method of regional assessment and a novel outcome measure in rheumatoid arthritis
000214 (2012)	Fatma Alibaz-Oner [Turquie] ; Sibel Zehra Aydin [Turquie] ; Haner Direskeneli [Turquie]	Advances in the diagnosis, assessment and outcome of Takayasu’s arteritis
000289 (2013)	Andrew Stone [Royaume-Uni] ; Christy Chuang-Stein [États-Unis]	Strong control over multiple endpoints: are we adding value to the assessment of medicines?
000314 (2010)	Ukihide Tateishi [Japon] ; Tomoyuki Imagawa [Japon] ; Noriko Kanezawa [Japon] ; Tetsuhiko Okabe [Japon] ; Kazuya Shizukuishi [Japon] ; Tomio Inoue [Japon] ; Shumpei Yokota [Japon]	PET assessment of disease activity in children with juvenile idiopathic arthritis
000361 (2016)	Xiaohui Wei [États-Unis] ; Jane R. Kenny [États-Unis] ; Leslie Dickmann [États-Unis] ; Romeo Maciuca [États-Unis] ; Caroline Looney [États-Unis] ; Meina T. Tang [États-Unis]	Assessment of Disease‐Related Therapeutic Protein Drug‐Drug Interaction for Etrolizumab in Patients With Moderately to Severely Active Ulcerative Colitis
000429 (2013)	C. Huemer [Autriche, Suisse]	Kindliches Rheuma – juvenile idiopathische Arthritis
000462 (2013)	Reinhard P. T. Rychlik [Allemagne]	Target patient population: how does the regulatory and reimbursement view differ? Insights from the German IQWiG
000506 (2013)	H. Sanner ; I. Sjaastad [Norvège] ; B. Flat	SAT0465 The Myositis Disease Activity Assessment Tool and the Printo Criteria for Clinically Inactive Disease Applied after Long-Term Follow-Up in Juvenile Onset Dermatomyositis.
000519 (2010)	Steven Simoens [Belgique] ; Thomas De Rijdt [Belgique] ; Paul Declerck	Monoclonal antibodies: indications, budget impact and use
000540 (2013)	N. Asai ; T. Kobayakawa ; K. Saito ; T. Shioura ; Y. Yabe [Japon] ; T. Kojima ; A. Kaneko [Japon] ; N. Ishiguro	AB0564 Continuation and remission rates of tocilizumab treatment based on improvement in patient global assessment: 2-year study based on the tsurumai biologics communication registry
000551 (2013)	K. Okamura [Japon] ; Y. Yonemoto [Japon] ; T. Kaneko [Japon] ; T. Kobayashi [Japon] ; K. Takeuchi [Japon] ; K. Takagishi [Japon]	AB0548 The assessment of anti-IL-6 treatments in patients with rheumatoid arthritis using FDG-PET/CT
000609 (2013)	A. Sagawa [Japon]	AB0508 Assessment of synovitis using ultrasonography in tocilizumab treated rheumatoid arthritis patients remaining in clinical remission
000612 (2014)	Andrew T. Chow [États-Unis] ; Justin C. Earp [États-Unis] ; Manish Gupta [États-Unis] ; William Hanley [États-Unis] ; Chuanpu Hu [États-Unis] ; Diane D. Wang [États-Unis] ; Stefan Zajic [États-Unis] ; Min Zhu [États-Unis]	Utility of population pharmacokinetic modeling in the assessment of therapeutic protein‐drug interactions
000700 (2013)	K. Minden [Allemagne] ; J. Klotsche [Allemagne] ; M. Niewerth [Allemagne] ; G. Horneff [Allemagne] ; A. Zink [Allemagne]	Biologikaregister JuMBO
000836 (2013)	M. Khraishi ; R. Aslanov [Canada] ; K. Doyle [Canada]	SAT0055 18-Month Cardiovascular Risk Assessment in Rheumatoid Arthritis (RA) Patients Treated by Biologic Response Modifiers
000837 (2013)	K. Okamura [Japon] ; Y. Yonemoto [Japon] ; T. Kaneko [Japon] ; C. Okura [Japon] ; T. Kobayashi [Japon] ; K. Takagishi [Japon]	SAT0494 Evaluation of Conventional Assessment of Tocilizumab Therapy in Patients with Rheumatoid Arthritis using FDG-PET/CT
000861 (2013)	Takaaki Ogoshi [Japon] ; Takashi Kido [Japon] ; Kazuhiro Yatera [Japon] ; Keishi Oda [Japon] ; Toshinori Kawanami [Japon] ; Hiroshi Ishimoto [Japon] ; Noriho Sakamoto [Japon] ; Arisa Sano [Japon] ; Chiharu Yoshii [Japon] ; Shohei Shimajiri [Japon] ; Hiroshi Mukae [Japon]	Assessment of Pathologically Diagnosed Patients with Castleman’s Disease associated with Diffuse Parenchymal Lung Involvement Using the Diagnostic Criteria for IgG4-Related Disease
000A54 (2011)	Homam Alkaied [États-Unis] ; Kassem Harris [États-Unis] ; Dany Elsayegh [États-Unis] ; Inga Khachaturova [États-Unis] ; Michael Awasum [États-Unis] ; Seema Varma [États-Unis]	Does Kaposi’s sarcoma predict multicentric Castleman disease in the presence of generalized lymphadenopathy?
000B26 (2016)	Charlotte R. Rawlings [Royaume-Uni] ; Georgina A. Fremlin [Royaume-Uni] ; Julian Nash [Royaume-Uni] ; Keith Harding [Royaume-Uni]	A rheumatology perspective on cutaneous vasculitis: assessment and investigation for the non‐rheumatologist
000B66 (2014)	W. H. Boehncke [Suisse] ; A. Qureshi [États-Unis] ; J. F. Merola [États-Unis] ; D. Thaçi [Allemagne] ; G. G. Krueger [États-Unis] ; J. Walsh [États-Unis] ; N. Kim [États-Unis] ; A. B. Gottlieb [États-Unis]	Diagnosing and treating psoriatic arthritis: an update

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "assessment" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "assessment" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    assessment
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021